Acquired immunodeficiency syndrome-related primary cerebral lymphoma

Clinical Oncology

Volumn 11, Issue 1, 1999, Pages 6-14

  Khoo, V S ^a   Liew, K H ^b  

^a INSTITUTE OF CANCER RESEARCH   (United Kingdom)

^b PETER MACCALLUM CANCER CENTRE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

HYDROXYUREA; LOMUSTINE; METHOTREXATE; PROCARBAZINE; STEROID; THIOTEPA; VINCRISTINE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; BRAIN LYMPHOMA; CLINICAL FEATURE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; PATHOGENESIS; PRIORITY JOURNAL; REVIEW;

EID: 0033032254     PISSN: 09366555     EISSN: None     Source Type: Journal    
DOI: 10.1053/clon.1999.9003     Document Type: Review

References (82)

1. DeAngelis L M, Yahalom J. Primary central nervous system lymphoma. DeVita V T, Hellman S, Rosenberg S A. Cancer: principles and practice of oncology. 1997;223-241 Lippincott-Raven, Philadelphia, PA:
2. Freeman C, Shustik C, Brisson M L. Primary malignant lymphoma of the central nervous system. Cancer. 58:1986;1106-1111.
3. Zimmerman R. Central nervous system lymphoma. Radiol Clin North Am. 28:1990;697-721.
4. Hochberg F H, Loeffler J S, Prados M. The therapy of primary brain lymphoma. J Neurooncol. 10:1991;191-210.
5. Chaisson R E. HIV infection: the world picture in 1992. Infect Med. 1992;6-10.
6. Cote T R, Manns A, Hardy C R. Epidemiology of brain lymphoma among people with or without acquired immunodeficiency syndrome. J Natl Cancer Inst. 85:1996;704-710.
7. Levine A M. AIDS-related malignancies: the emerging epidemic. J Natl Cancer Inst. 85:1993;1382-1397.
8. JAMA. 258:1987;1143-1149.
9. Kalter S P, Riggs S A, Cabanillas F. Aggressive non- Hodgkin's lymphomas in immunocompromised homosexual males. Blood. 66:1985;655-659.
10. Mendenhall N P, Thar T L, Agee O F. Primary lymphoma of the central nervous system. Computerized tomography scan characteristics and treatment results for 12 cases. Cancer. 1983;1993-2000.
11. Murray K, Kun L, Cox J. Primary malignant lymphoma of the central nervous system. Results of treatment of 11 cases and review of the literature. J Neurosurg. 1986;600-607.
12. Gill P S, Levine A M, Meyer P R. Primary central nervous system lymphoma in homosexual men: clinical, immunologic and pathologic factors. Am J Med. 78:1985;742-748.
13. So Y T, Beckstead J H, Davis R L. Primary central nervous system lymphoma in acquired immune deficiency syndrome: a clinical and pathological study. Ann Neurol. 20:1986;566-572.
14. Rosenblum M L, Levy R M, Bredesen D E. Primary central nervous system lymphomas in patients with AIDS. Ann Neurol. 23:1988;S13-S16.
15. Baumgartner J E, Rachlin J R, Levy R M. AIDS associated primary CNS lymphoma. ASCO Proc. 7:1988;83.
16. Poon T, Matoso I, Tchertkoff V. CT features of primary cerebral lymphoma in AIDS and non-AIDS patients. J Comput Assist Tomogr. 13:1989;6-9.
17. Donahue B, Cooper J S, Newell J. Results of empiric radiotherapy for HIV-associated CNS lymphoma. Int J Radiat Oncol Biol Phys. 17:1989;233.
18. Formenti S C, Gill P S, Lean E. Primary central nervous system lymphoma in AIDS. Cancer. 63:1989;1101-1107.
19. Quivey J M, Berson A, Wara W. The role of radiotherapy in the treatment of AIDS related non-Hodgkin's lymphoma. ASCO Proc. 8:1989;22.
20. Baumgartner J E, Rachlin J R, Beckstead J H. Primary central nervous system lymphomas; natural history and response to radiation therapy in 55 patients with acquired immune deficiency syndrome. J Neurosurg. 73:1990;206-211.
21. Remick S C, Diamond C, Migliozzi J A. Primary central nervous system lymphoma in patients with and without the acquired immune deficiency syndrome. Medicine. 69:1990;345-360.
22. Morgello S, Petito C K, Mouradian J A. Central nervous system lymphoma in the acquired immunodeficiency syndrome. Clin Neuropathol. 9:1990;205-215.
23. DeWeese T L, Hazuka M B, Hommel D J. AIDSrelated non-Hodgkin's lymphoma: the outcome and efficacy of radiation therapy. Int J Radiat Oncol Biol Phys. 20:1991;803-808.
24. Goldstein J D, Dickson D W, Moser F G. Primary central nervous system lymphoma in acquired immune deficiency syndrome. Cancer. 67:1991;2756-2765.
25. Nisce L Z, Kaufmann T, Metroka C. Radiation therapy in patients with AIDS-related central nervous system lymphomas. JAMA. 267:1992;1921-1922.
26. Chappell E T, Guthrie B L, Orenstein J. The role of stereotactic biopsy in the management of HIV-related focal brain lesions. J Neurosurg. 30:1992;825-829.
27. Ozsahiin M, Touboul E, Schlienger M. Primary central nervous lymphoma in patients with acquired immunodeficiency syndrome: results of radiation therapy. Bull Cancer Radiother. 79:1992;77-86.
28. Forsyth P A, Yahalom J, DeAngelis L M. Combinedmodality therapy in the treatment of primary central nervous system lymphoma in AIDS. Neurology. 44:1994;1473-1479.
29. Ling S M, Roach M, Larson D A. Radiotherapy of primary central nervous system lymphoma in patients with and without human immunodeficiency virus. Cancer. 73:1994;2570-2582.
30. Donahue B R, Sullivan J W, Cooper J S. Additional experience with empiric radiotherapy for presumed human immunodeficiency virus-associated primary central nervous system lymphoma. Cancer. 76:1995;328-332.
31. Luzzati R, Ferrari S, Nicolato A. Stereotactic brain biopsy in human immunodeficiency virus-infected patients. Arch Intern Med. 156:1996;565-568.
32. Kaufmann T, Nisce L Z, Coleman M. A comparison of survival of patients treated for AIDS-related central nervous system lymphoma with and without tissue diagnosis. Int J Radiat Oncol Biol Phys. 36:1996;429-432.
33. Khoo V S, Liew K H, Sexton M J. Acquired immunodeficiency syndrome (AIDS)-related primary cerebral lymphoma: response to irradiation. Br J Cancer. 76:1997;52.
34. Corn B W, Donahue B R, Rosenstock J G. Performance status and age as independent predictors of survival among AIDS patients with primary CNS lymphoma: a multi-variate analysis of a multi-institutional experience. Cancer J Sci Am. 3:1997;53-56.
35. Henry J M, Heffner R R, Dillard S H. Primary malignant lymphomas of the central nervous system. Cancer. 1974;1293-1302.
36. Neuwelt E A, Golman D L, Dahlborg S A. Primary CNS lymphoma treated with osmotic blood-brain barrier disruption: prolonged survival and preservation of cognitive function. J Clin Oncol. 9:1991;1580-1590.
37. Nelson D F, Martz K L, Bonner H. Non-Hodgkin's lymphoma of the brain: can high dose, large volume radiation therapy improve survival? Report on a prospective trial by the Radiation Therapy Oncology Group (RTOG) - RTOG8315. Int J Radiat Oncol Biol Phys. 23:1992;9-17.
38. DeAngelis L M, Yahalom J, Thaler H T. Combined modality therapy for primary central nervous system lymphoma. J Clin Oncol. 10:1992;635-643.
39. Monfardini S, Vaccher E, Foa R. AIDS-associated non-Hodgkiin's lymphoma in Italy: intravenous drug users versus homosexual men. Ann Oncol. 1:1990;203-211.
40. Levy R M, Bredesen D E, Rosenblum M L. Neurological manifestations of the acquired immunodeficiency syndrome (AIDS): experience at UCSF and review of the literature. J Neurosurg. 62:1985;475-495.
41. Pluda J M, Yarchoan R, Jaffe E S. Development of non-Hodgkin's lymphoma in a cohort of patients with severe human immunodeficiency virus (HIV) infection on long-term antiretroviral therapy. Ann Intern Med. 113:1990;276-282.
42. Welch K, Finkbeiner W, Aplers C E. Autopsy findings in the acquired immune deficiency syndrome. JAMA. 252:1984;1152-1159.
43. MacMahon E ME, Glass J D, Hayward S D. Epstein-Barr virus in AIDS-related primary central nervous system lymphoma. Lancet. 338:1991;969-973.
44. Gill P S, Levine A M, Krailo M. AIDS-related malignant lymphoma: results of prospective treatment trials. J Clin Oncol. 5:1987;1322-1328.
45. Iglesias-Rozas J R, Bantz B, Adler T. Cerebral lymphoma in AIDS: clinical, radiological, neurological and immunopathological study. Clin Neuropathol. 10:1991;65-72.
46. Levine A M. Lymphoma related to human immunodeficiency virus: the epidemic shifts. J Natl Cancer Inst. 83:1991;662-663.
47. Chamberlain M C. Long survival in patients with acquired immune deficiency syndrome-related primary central nervous system lymphoma. Cancer. 73:1994;1728-1730.
48. Northfelt D W, Kaplan L D. Clinical manifestations and treatment of HIV-related non-Hodgkin lymphoma. Cancer Surv. 10:1991;121-133.
49. Ahmed T, Wormser G P, Stahl R E. Malignant lymphomas in a population at risk for acquired immune deficiency syndrome. Cancer. 60:1987;719-723.
50. Frizzera G, Rosai J, Dehner F P. Lymphoreticular disorders in primary immunodeficiencies: new findings based on an up-to-date histologic classification of 35 cases. Cancer. 46:1980;692-699.
51. Schenck S A, Penn L. De-novo brain tumours in renal transplant recipients. Lancet. 1:1971;983-986.
52. Wilkinson A H, Smith J L, Hunsicker L G. Increased frequency of post transplant lymphomas in patients treated with cyclosporin, azathioprine and prednisolone. Transplantation. 47:1989;293-296.
53. Pelicci P G, Knowles D M, Arlin Z A. Multiple monoclonal B cell expansions and c-myc oncogene rearrangements in acquired immunodeficiency syndrome related lymphoproliferative disorders. J Exp Med. 164:1986;2049-2060.
54. Birx D L, Redfield R R, Tosato G. Defective regulation of Epstein-Barr virus infection in patients with acquired immunodeficiency syndrome (AIDS) or related disorders. N Engl J Med. 314:1986;874-879.
55. Knowles D M, Chanulak G A, Subar M. Lymphoid neoplasia associated with the acquired immunodeficiency syndrome (AIDS). Ann Intern Med. 108:1988;744-753.
56. Bashir R M, Harris N L, Hochberg F H. Detection of Epstein-Barr virus in CNS lymphomas by in situ hybridization. Neurology. 39:1989;813-817.
57. Hamilton-Dutiot S J, Raphael M, Audouin J. In situ demonstration of Epstein-Barr virus small RNAs (EBER 1) in acquired immunodeficiency syndrome-related lymphomas: correlation with tumor morphology and primary site. Blood. 82:1993;619-624.
58. Cinque P, Brytting M, Vago L. Epstein-Barr virus DNA in cerebrospinal fluid from patients with AIDSrelated primary lymphoma of the central nervous system. Lancet. 342:1993;398-401.
59. Monforte A D, Cinque P, Vago L. A comparison of brain biopsy and CSF-PCR in the diagnosis of CNS lesions in AIDS patients. J Neurol. 244:1997;35-39.
60. Henderson S, Rowe M, Gregory C. Indication of bcl-2 expression by Epstein-Barr virus latent membrane protein 1 protects infected B-cells from programmed cell death. Cell. 65:1991;1107-1115.
61. Camilleri-Broet S, Davi F, Feuillard J. High expression of latent membrane protein 1 of Epstein-Barr virus and bcl-2 oncoprotein in acquired immunodeficiency syndrome-related primary brain lymphoma. Blood. 86:1995;432-435.
62. Meeker T C, Shiramizu B, Kaplan L. Evidence for moloecular subtypes of HIV-associated lymphoma: division into peripheral monoclonal lymphoma, peripheral polyclonal lymphoma, and central nervous system lymphoma. AIDS. 5:1991;669-774.
63. Boyle M J, Swanson C E, Turner J J. Definition of two distinct types of AIDS-associated non-Hodgkin lymphoma. Br J Haematol. 1990;506-512.
64. Lowenthal D A, Straus D J, Campbell S W. AIDSrelated lymphoid neoplasia: The Memorial Hospital experience. Cancer. 61:1988;2325-2337.
65. Corn B W, Donahue B R, Rosenstock J G. Palliation of AIDS-related primary lymphoma of the brain: observations from a multi-institutional database. Int J Radiat Oncol Biol Phys. 38:1997;601-605.
66. Orron D E, Kuhn M J, Malholtra V. Primary cerebral lymphoma in acquired immunodeficiency syndrome (AIDS) - CT manifestations. Comput Med Imaging Graph. 13:1989;207-214.
67. Snider W D, Simpson D M, Nielson S. Neurological complications of acquired immune deficiency syndrome: analysis of 50 patients. Ann Neurol. 14:1983;403-418.
68. Dina T S. Primary central nervous system lymphoma versus toxoplasmosis in AIDS. Radiology. 179:1991;823-828.
69. Ciricillo S R, Rosenblum M L. Use of CT and MR imaging to distinguish intracranial lesions and define the need to biopsy in AIDS patients. J Neurosurg. 73:1990;720-724.
70. Hoffman J M, Waskin H A, Schifter T. FDG-PET in differentiating lymphoma from non-malignant central nervous system lesions in patients with AIDS. J Nucl Med. 34:1993;567-575.
71. Pierce M A, Johnson M D, Maciunas R J. Evaluating contrast-enhancing brain lesions in patients with AIDS by using positron emission tomography. Ann Intern Med. 123:1995;594-598.
72. Loureiro C, Gill P S, Meyer P R. Autopsy findings in AIDS-related lymphoma. Cancer. 62:1988;735-739.
73. Vital C, Monlun E, Vital A. Concurrent herpes simplex type 1 necrotizing encephalitis, cytomegalovirus ventriculoencephalitis and cerebral lymphoma in an AIDS patient. Acta Neuropathol. 89:1995;105-108.
74. Levy R M, Russel E, Yungbluth M. The efficacy of image-guided stereotactic brain biopsy in neurologically symptomatic acquired immunodeficiency syndrome patients. Neurosurgery. 30:1992;186-190.
75. Mathews C, Barba D, Fullerton S C. Early biopsy versus empiric treatment with delayed biopsy of non-responders in suspected HIV-associated toxoplasmosis. AIDS. 9:1995;1243-1250.
76. Porter S B, Sande M A. Toxoplasmosis of the central nervous system in the acquired immunodeficiency syndrome. N Engl J Med. 327:1992;1643-1648.
77. Luft B J, Hafner R, Korzun A H. Toxoplasmosis encephalitis in patients with the acquired immunodeficiency syndrome. N Engl J Med. 329:1993;995-1000.
78. Andrews B T, Kenefick T P. Neurosurgical management of the acquired immunodeficiency syndrome. West J Med. 158:1993;249-253.
79. Feiden W, Bise K, Steude U. The stereotactic biopsy diagnosis of focal intracerebral lesion in AIDS patients. Acta Neurol Scand. 87:1993;228-233.
80. Ianoangeli M, Roselli R, Antinori A. Experience with brain biopsy in acquired immune deficiency syndrome-related focal lesions of the central nervous system. Br J Surg. 81:1994;1508-1511.
81. Viswanathan R, Ironside J, Bell J E. Stereotactic brain biopsy in AIDS patients: does it contribute to patient management? Br J Neurosurg. 8:1994;307-311.
82. Kaplan L D, Abrams D I, Feigal E. AIDS-associated non-Hodgkin's lymphoma in San Francisco. JAMA. 261:1989;719-724.